A LONGITUDINAL-STUDY ON THE INCIDENCE AND TRANSMISSION PATTERNS OF HIV, HBV AND HCV INFECTION AMONG DRUG-USERS IN AMSTERDAM

被引：138

作者：

VANAMEIJDEN, EJC

VANDENHOEK, JAR

MIENTJES, GHC

COUTINHO, RA

机构：

[1] The Department of Public Health and Environment, Municipal Health Service, Amsterdam, 1000 HE

来源：

EUROPEAN JOURNAL OF EPIDEMIOLOGY | 1993年 / 9卷 / 03期

关键词：

HUMAN IMMUNODEFICIENCY VIRUS; SURVEILLANCE; HEPATITIS-B VIRUS; HEPATITIS-C VIRUS; SUBSTANCE ABUSE; INTRAVENOUS; RISK FACTORS; INCIDENCE; FOLLOW-UP STUDIES; THE NETHERLANDS;

D O I：

10.1007/BF00146260

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

In the present study data on the incidence of HBV and HCV were used to indicate the prevalence of and trends in risk behavior, assuming that drug users (DUs) who become infected with HBV or HCV are also at risk for infection with HIV. In addition, we determined to that extent the transmission patterns of HIV, HBV and HCV differed. DUs were selected from a cohort study in Amsterdam, had at least one follow-up visit between December 1985 and September 1989 and reported never to have had homosexual contacts. Among 305 DUs, of whom 70% injected recently, the prevalence of HIV, HBV and HCV were 31%, 68% and 65% respectively. These prevalences were strongly interrelated and the same risk factors were found. The cumulative incidence of either HIV or HBV or HCV was 30% among prevalent HIV-negatives. Despite a previously reported reduction in risk behavior, only the HIV incidence tended to decrease initially, and after 1986 the incidences of HIV, HBV and HCV remained disturbingly high and stable (mean: 4, 9 and 10 per 100 person-years, respectively). As at present HBV appears to be transmitted more heterosexually than HIV in our study group and the HIV-epidemic may follow the HBV-epidemic in its transmission patterns, preventive activities targeted at both injecting and sexual behavior should be expanded.

引用

页码：255 / 262

页数：8

共 35 条

[1]

Alexander N.J., Sexual transmission of human immunodeficiency virus: virus entry into the male and female tract, Fertil. Steril., 54, pp. 1-18, (1990)

[2]

Alter H.J., Purcell R.H., Shih J.W., Melpolder J.C., Houghton M., Choo Q.L., Kuo G., Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis, N. Engl. J. Med., 321, pp. 1494-1500, (1989)

[3]

Alter M.J., Coleman P.J., Alexander W.J., Kramer E., Miller J.K., Mandel E., Hadler S.C., Margolis H.S., Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis, JAMA, 262, pp. 1201-1205, (1989)

[4]

Alter M.J., Hadler S.C., Judson F.N., Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection, JAMA, 264, pp. 2231-2235, (1990)

[5]

van Ameijden E.J.C., van den Hoek J.A.R., van Haastrecht H.J.A., Coutinho R.A., The harm reduction approach and risk factors for HIV seroconversion in injecting drug users, Amsterdam, Am. J. Epidemiol., 136, pp. 136-143, (1992)

[6]

Blower S., Behaviour Change and stabilization of seroprevalence in communities of injecting drug users: correlation or causation, J. AIDS, 4, pp. 920-923, (1991)

[7]

Buning E.C., Coutinho R.A., van Brussel G.H.A., van Santen G.W., van Zadelhof A.W., Preventing AIDS in drug addicts in Amsterdam (letter), Lancet, 65, pp. 146-150, (1986)

[8]

Chamot E., Hirschel B., Wintsch J., Robert C.F., Gariel V., Deglon J.J., Yerly S., Perrin L., Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users, AIDS, 4, pp. 1275-1277, (1990)

[9]

Coombs R.W., Collier A.N., Allain J.P., Nikora B., Leuther M., Gjerset G.F., Corey L., Plasma viremia in human immunodeficiency virus infection, N. Engl. J. Med., 321, pp. 1626-1631, (1989)

[10]

van Doornum G.J.J., Hooykaas C., Cuypers M.T., van der Linden M.M.D., Coutinho R.A., Prevalence of hepatitis C virus infection among heterosexuals with multiple partners, J. Med. Virol., 35, pp. 22-27, (1991)

← 1 2 3 4 →